• Revenue at ₹958.39 crore versus ₹601.87 crore, UP 59.23% YoY.
• Net profit at ₹538.17 crore versus ₹264.29 crore, UP 103.63% YoY.

• Net premium income at ₹1.2 lakh crore versus ₹1.14 lakh crore, UP 4.71% YoY.
• Net profit at ₹10,985 crore versus ₹10,551 crore, UP 4.11% YoY

• Consolidated Total Income of ₹14,966 crores grew 21% sustaining healthy growth momentum.
• Jewellery portfolio grew 19% to ₹12,797 crores (excluding bullion and digi-gold soles) demonstrating resilience despite an elevated gold price environment and challenging market conditions.
• Watches division delivered an exceptional growth of 24% achieving ₹1,273 crores, marking one of its best-ever quarters.
• Its eyecare segment reported a total Income of ₹238 crores in Q1FY26, growing 13% over Q1FY25.
• Its eyecare business recorded an EBIT of ₹20 crores clocking a margin of 8.4% for the quarter, driven by seasonal trends during the quarter, sunglasses growth significantly outpaced prescription products (lenses and frames).

Commenting on the results, CK Venkataraman, the Managing Director of Titan, said: "Q1 FY26 has been an encouraging start to the fiscal year with 21% consolidated revenue growth, demonstrating the strength of our diversified business model. Our Jewellery business continues to show remarkable resilience despite headwinds from elevated gold prices. Consumer confidence in gold as both adornment and store of value remains intact, supporting our market leadership position. Watches delivered one of its best-ever quarters, achieving exceptional performance in both revenue growth and margins. This validates our premiumization strategy and the strong consumer connect our brands have established. EyeCare has been clocking three quarters of double-digit growth, and we are confident of accelerating this momentum in the coming quarters as we expand our reach and enhance our product offerings. Our Emerging brands of SKINN IRTH and Taneira have made substantial progress in optimizing their business mix and are well-positioned to capture greater market share. Our international operations continue to deliver strong growth, opening new avenues for expansion."

"We remain optimistic about our growth trajectory and our ability to create long-term value across all business segments," he added.

• Net sales at ₹16,523 crore versus ₹13,266 crore, UP 24.6% YoY
• Net profit at ₹1,091 crore versus ₹715 crore, UP 52.59% YoY
• EBITDA at ₹1,830 crore versus ₹1,247 crore, UP 46.8% YoY
• EBITDA margin at 11.08% versus 9.40%

Q1 Results Live Updates: Kalyan Jewellers PAT rises 48.6% to ₹178 crore, revenue up 31.5%

Q1 Results Live Updates: Kalyan Jewellers net profit rises 48.55% to ₹264.08 crore in Q1 FY26 compared to ₹177.76 crore a year back.

Its revenue from operations stood at ₹7,268.47 crore, an increase of 31.48% from ₹5,527.81 crore.

Q1 Results Live Updates: Godrej Consumer Products reported a 0.39% growth in its consolidated net profit to ₹452.45 crore versus ₹450.69 crore a year back.

It also declared an interim dividend of ₹5 per share. The record date is August 13, while the payment date is September 6.

Q1 Results Live Updates: Solar Industries reported an 18.23% surge in its consolidated PAT attributable to owners of the company at ₹338.7 crore versus ₹286.46 crore in Q1 FY25.

Q1 Results Live Updates: NBCC (India) reported a 26.28% rise in its consolidated PAT to ₹132.12 crore in the April-June period of FY26. A year back, the post-tax profit stood at ₹104.62 crore.

It has also announced an interim dividend of ₹0.21 per share. The record date is fixed as Wednesday, August 13.

• Revenue rises 3% at ₹1,316.56 crore vs ₹1,277.51 crore (YoY)
• Net profit Up 21.52% at ₹200.79 crore vs ₹165.22 crore (YoY)

Q1 Results Live Updates: Plywood manufacturer and supplier Century Plyboards posted a 50.59% increase in its net profit to ₹51.85 crore in the first quarter of the financial year 2025-26, compared to ₹34.43 crore a year back.

Q1 Results Live Updates: The revenue from operations of Emcure Pharmaceuticals rose 15.72% to ₹2,100.53 crore in the first quarter of FY26 vs ₹1,815.13 crore a year back.

Q1 Results Live Updates: Pharma major Emcure Pharmaceuticals' consolidated net profit attributable to owners of the company stood at ₹206.95 crore in the quarter ended June 2025, up 43.63% from ₹144.08 crore a year back.

• Consolidated PAT: ₹0.91 crore, down 96.76% YoY
• Revenue: ₹1,064.59 crore, down 7.8% YoY

Q1 Results Live Updates: Advik Capital's Board of Directors will meet on August 12 to consider and approve financial results for the latest June quarter.

Q1 Results Live Updates: Integrated building materials company Prism Johnson posted a consolidated net loss of ₹5.56 crore in Q1 FY26 as compared to ₹18.26 crore a year back.

Q1 Results Live Updates: The Board of Archies will be meeting on August 13 to consider and approve financial results for the quarter ending June 2025.